A team of researchers from Nagoya University in central Japan investigated how restrictions on children's activities during the COVID-19 pandemic affected their life habits and their abilities to perform physical activities.
The Global Virus Network (GVN) announced eleven members of the 2022 GVN Rising Star Mentorship Program. The newly elected members span eight countries around the globe.
In a series of experiments, scientists found that gene usage in the brains of patients with COVID-19 is similar to those observed in aging brains.
The Bloomberg American Health Initiative at the Johns Hopkins Bloomberg School of Public Health released a report today setting out 10 practical steps to address major causes of declining life expectancy in the U.S.
Here are some of the latest articles that have been added to the Behavioral Science channel on Newswise, a free source for journalists.
By August 2022, most children and adults younger than 60 years in Canada had been exposed to SARS-CoV-2 through a combination of vaccination and infection, according to a large study looking at blood antibodies published in CMAJ (Canadian Medical Association Journal)
Researchers at The Tisch Cancer Institute uncovered inflammatory markers that may predict which COVID-19 patients are more likely to respond to therapies like the anti-cancer drug pacritinib, according to phase 2 trial results published in JAMA Network Open in December.
The precise relationship between vaccine hesitancy and COVID-19 vaccination side effects has not previously been explored in vaccinated persons. A fundamental question arises in regard to the directionality of this vaccine hesitancy-vaccine side effect link, namely which variable predicts which. One possibility is that side effects from an earlier dose predict one’s vaccine hesitancy towards a later dose. Alternatively, one’s psychological negativity (hesitancy) towards an earlier dose could predict subsequent side effects from a later vaccination dose. The latter direction reflects a Nocebo effect, i.e., side effects driven by psychological factors rather than by an active treatment component. Results showed only the latter direction to be true. Namely, only earlier vaccine hesitancy towards the second COVID-19 dose predicted subsequent nocebo side-effects following the booster vaccination. To put this in perspective up to 16% of one’s vaccine side effects were explained by earlier va
New symptoms may appear in children up to a year after initial infection with Covid-19, finds a new study led by UCL researchers.
SEATTLE — Dec. 1, 2022 — The 64th Annual Meeting and Exposition of the American Society of Hematology (ASH) will take place virtually and in person Dec. 10-13 in New Orleans, Louisiana.
First discovered a year ago in South Africa, the SARS-CoV-2 variant later dubbed “Omicron” spread across the globe at incredible speed.
Immune T cells are continuing to target the spike protein of SARS-CoV-2 variants of concern, although mutations are making some T cells less effective, according to new research.
SARS-CoV-2 vaccines protected infant rhesus macaques against 1 severe lung disease after high dose challenge one year after vaccination.
Long COVID patients can experience many of the same lingering negative effects on their physical, mental, and social well-being as those experienced by people who become ill with other, non-COVID illnesses.
uando comenzó la pandemia de COVID-19, los pacientes con síndrome de covid prolongada, también conocido como síndrome poscovid, informaron que tenían problemas con el pensamiento. A esto, se ha llegado a conocer como bruma mental y, aunque no sea el término médico oficial, la expresión es ahora una parte permanente de la discusión sobre la covid prolongada. En esta advertencia de un experto, el Dr. Greg Vanichkachorn, director del Programa para rehabilitación de la actividad después de la covid en Mayo Clinic, describe los problemas frecuentes de los pacientes.
Nos primeiros dias da pandemia de COVID-19, pacientes com a síndrome da COVID longa (também conhecida como síndrome pós-COVID), relataram problemas de raciocínio. Isso ficou conhecido como confusão ou névoa mental e, embora não seja um termo médico oficial, tornou-se parte permanente da discussão sobre a COVID longa. Neste alerta do especialista, o Dr. Greg Vanichkachorn, M.D., diretor do Programa de Reabilitação de Atividades da COVID da Mayo Clinic, descreve os problemas comuns vivenciados pelos pacientes.
مدينة روتشستر، ولاية مينيسوتا— في الأيام الأولى لجائحة فيروس كورونا المستجد (كوفيد-19)، أبلغ المرضى المصابون بمتلازمة فيروس كورونا المستجد طويل الأمد، والمعروفة أيضًا باسم متلازمة ما بعد فيروس كورونا المستجد، عن مشاكل في التفكير. ثم أصبح هذا يُعرف باسم ضباب الدماغ، وعلى الرغم من أنه ليس مصطلحًا طبيًا رسميًا، فقد أصبح جزءًا دائمًا من مناقشات فيروس كورونا المستجد طويل الأمد. وفي هذا المقال، يصف جريج فانيشكاتورن، دكتور الطب، مدير برنامج مايو كلينك لتأهيل النشاط بعد فيروس كورونا المستجد، المشكلات الشائعة التي يعاني منها المرضى.
Overweight women are more likely to experience symptoms of long Covid according to new research from the University of East Anglia.
A survey from the American Academy of Sleep Medicine reveals that Americans seem to be sleeping better now compared with 2021. Nearly one-third of Americans (31%) say they have experienced “COVID-somnia" since the beginning of the pandemic, a 25% decrease compared with the 2021 survey (56%).
The study, a collaboration between Clover and the International Vaccine Institute, showed that a household contact was 84% less likely to get a SARS-CoV-2 infection when the infected household member had received SCB-2019 (CpG 1018/Alum) compared to placebo
In Brazil, a group of researchers has reported the largest outbreak to date of COVID-associated candidemia caused by the same drug-resistant strain of Candida parapsilosis, a fungus that invades the bloodstream and can lead to death.
Mechanisms involved in the rapid, severe progression of fibrosis in the lung tissues of COVID-19 patients, a potentially fatal complication of the virus that damages and scars the lungs, have been uncovered by researchers led by UTHealth Houston.
With COVID-19 and flu cases rising, and RSV (respiratory syncytial virus) affecting many young children, experts are bracing for a “tripledemic” of respiratory viruses this holiday season.
Researchers find correlation between medications in sewage treatment plants and hospital data
COVID-19 has had a lasting global health impact that continues to challenge the health care system.
School closures during the COVID-19 pandemic have “severely ruptured” the social and emotional development of some of the world’s poorest children, as well as their academic progress, new evidence shows.
Findings from a Johns Hopkins Medicine research study published today in JAMA Network Open provide strong evidence that people who are pregnant and have been infected with SARS-CoV-2 (the virus that causes COVID-19) can safely take the antiviral drug Paxlovid to reduce the possibility of severe disease.
The Pfizer-BioNTech COVID-19 vaccine limits transmission, hospitalization, and death from COVID-19 even among patients infected by variants of the virus, but the effectiveness of antibodies it generates diminishes as patients get older, according to a study by UT Southwestern researchers.
Groundbreaking research by Argonne National Laboratory finds new method to quickly identify COVID-19 virus variants. Their work wins the Gordon Bell Special Prize.
Since March 2020, COVID-19-related deaths claimed over a million lives in the U.S. alone.
While some feared that New Yorkers would re-fill prescriptions to stockpile opioid medications in the early weeks of the COVID-19 lockdown much in the way people hoarded toilet paper, in fact, New York State opioid prescriptions declined in the period around the March 20, 2020 “PAUSE” order, according to new research.
In a new Rapid and Living Practice Points, the American College of Physicians (ACP) summarizes the best available evidence about the use of pharmacologic and biologic treatments of COVID-19 in the outpatient setting. Outpatient Treatment of Confirmed Mild or Moderate COVID-19: Living and Rapid Practice Points from the American College of Physicians (Version 1), is published in Annals of Internal Medicine.
A brief research report found that despite 20.8 percent fewer COVID-19 deaths occurring in the second year of the COVID-19 pandemic, 7.4 percent more years of life were lost due to a shift in COVID-19 mortality to relatively younger people. The report is published in Annals of Internal Medicine.
An observational study of COVID-19 standard of care (SOC) measures found improvements in recovery and mortality over time in adults hospitalized with COVID-19 and investigated changes in SOC that may explain these improvements. The study is published in Annals of Internal Medicine.
A study of more than 1,000 health care workers was unable to establish whether medical masks are significantly less effective at preventing COVID-19 infection than N95 respirators in hospital settings. The findings varied across countries, which were studied during different times in the pandemic, and uncertainty in the estimates of effect limit definitiveness of findings. The study is published in Annals of Internal Medicine.
An award-winning scheme that saw community pharmacists support patients to understand the benefits of being jabbed against Covid-19 and overcome initial hesitancy proved hugely successful, new research by an expert from Kingston University has shown.
Once considered a potentially static field of medicine, the discipline of studying infectious diseases has proven to be dynamic as emerging and reemerging infectious diseases present continuous challenges, Anthony S. Fauci, M.D., writes in a perspective in The New England Journal of Medicine.
In an intensive look at the effects of the virus causing COVID-19 on patients’ microbiome – the collection of microorganisms that live in and on the human body – Rutgers scientists found that acute infection disrupts a healthy balance between good and bad microbes in the gut, especially with antibiotic treatment.
Researchers working with Sbarro Health Research Organization (SHRO) have published a paper examining the possible links between neurological involvement and respiratory damage due to COVID-19.
School closures due to the COVID-19 pandemic affected learning to varying degrees in different countries. A new study sheds light on what this learning loss will mean for countries' human capital in the decades to come.
Researchers of the University of Bristol-led study, published in Science Advances today [23 November], say their findings could lead to the development of a pan-coronavirus treatment to defeat all coronaviruses.
Researchers at the University of São Paulo (USP) in Brazil have found that severe COVID-19 is associated with an imbalance in an important immune system signaling pathway.
A new study assesses the number of lives lost to the COVID-19 pandemic in Russia and introduces a novel methodology that will help to get a clearer view of pandemics in the future.
Research by psychologists from the School of Psychology at Swansea University found that people’s fear of COVID-19 has led to worsened mental health.
The COVID-19 pandemic has led to an explosion of clinical research resulting in the development of a variety of vaccines and treatments, although the efficacy of some remains controversial.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
